Reuters: Intranasal Vaccine Aims to Block Virus at Point of Entry

An experimental intranasal COVID-19 vaccine now being tested for the first time in humans showed promising results in monkeys, researchers will report on Thursday at ASV 2021, the annual meeting of the American Society of Virology.


To read the full article, click here.